Avidity Biosciences Inc. (RNA): Price and Financial Metrics

Avidity Biosciences Inc. (RNA): $45.76

0.57 (-1.23%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

D

Add RNA to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#311 of 329

in industry

RNA Price/Volume Stats

Current price $45.76 52-week high $49.41
Prev. close $46.33 52-week low $4.82
Day low $45.04 Volume 755,100
Day high $46.38 Avg. volume 1,364,720
50-day MA $43.75 Dividend yield N/A
200-day MA $29.57 Market Cap 4.38B

RNA Stock Price Chart Interactive Chart >


Avidity Biosciences Inc. (RNA) Company Bio


Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease; to design, engineer, and develop therapeutics that combine tissue selectivity of monoclonal antibodies and the precision of oligonucleotide therapies to access previously undruggable tissue and cell types, and target underlying genetic drivers of diseases. In addition, it develops muscle programs, which focuses on the treatment of muscle atrophy, duchenne muscular dystrophy, facioscapulohumeral muscular dystrophy, and Pompe diseases. Avidity Biosciences, Inc. was founded in 2012 and is based in La Jolla, California.


RNA Latest News Stream


Event/Time News Detail
Loading, please wait...

RNA Latest Social Stream


Loading social stream, please wait...

View Full RNA Social Stream

RNA Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!